Joseph J. Wolk

October 17, 2026

Johnson & Johnson: Key Takeaways for Long-Term Investors. Recent coverage highlighted three takeaways for long‑term investors in Johnson & Johnson. The article notes the company's steady dividend yield of about 3.1% and its diversified healthcare portfolio. It also points to a relatively high price‑to‑earnings multiple, suggesting expectations of continued growth. These points are relevant as the stock trades near a long‑standing support level.

October 9, 2026

Prudential Financial Discusses Japan Business Update After FSA Orders. Prudential Financial released a transcript of a discussion about its Japan operations. The company explained the steps it is taking after orders from the Financial Services Agency, including remediation measures and a plan for moving forward. These updates give investors a clearer view of how regulatory actions may affect the insurer’s business and its long‑term strategy.

October 17, 2026

Kenvue Affected by Kimberly-Clark Bond Sale and Earnings Outlook. Kimberly-Clark is preparing a bond sale before its planned purchase of Kenvue, which could influence Kenvue's capital structure and investor perception. Analysts expect Kenvue's next quarterly earnings to reflect the impact of the acquisition and current market conditions. The company’s 2026 profit outlook remains unchanged, and consumer stocks overall were mixed in recent trading sessions.